As part of the BMEGS mission we aim to provide all of our graduate students with the opportunity to learn more about different career paths after grad school!

For our monthly networking series we have Mr. Daniel Lee joining us, as the president of Tissue Regenix Group, this will be a very informative and interesting session. We hope you will make the time to join in on this virtual meeting!

Meeting Time: August 4th at 11:30 a.m. - 1:00 p.m.
Zoom Link: https://utsa.zoom.us/j/91063620140?pwd=M2l5ZTRuNTludmpyS05WV1Y2a01aZz09 


BIO:
Daniel R. Lee has nearly 30 years experience in the medical device and biologics industry ranging from product innovation to commercialization to corporate management. He joined CellRight Technologies® as President of U.S. Operations in January 2019. Prior to joining CellRight, Danny was the Chief Executive Officer for Scaffold Biologics and Aperion Biologics. His previous senior management roles included global marketing for OsteoBiologics (acquired by Smith & Nephew Endoscopy in 1996) and marketing activities for Regeneration Technologies (now RTI Surgical), a leading allograft tissue processor. Danny spent the first ten years of his career in R&D with the U.S. Surgical Corporation (now Medtronic). Danny received his B.E.S. degree in Materials Science and Engineering from the Johns Hopkins University and his M.S. in Biomedical Engineering from the University of Alabama at Birmingham. He has thirteen patents on implants and instruments used in orthopedic and general surgery.


Best wishes, 
BMEGS-SA Officers